Important safety considerations include monitoring for pancreatitis (treatment should be discontinued if suspected), caution in patients with pre-existing diabetic retinopathy, and awareness of potential gallbladder disease
All medications are FDA-approved and prescribed based on your health profile
Contact your GP if constipation persists for more than one week despite treatment, or if you experience severe abdominal pain, rectal bleeding, nausea and vomiting, or symptoms of bowel obstruction
Explore Semaglutide Treatment Options at Klinic At Klinic in Peabody, we offer a range of FDA-approved semaglutide and GLP-1 weight loss solutions tailored to your needs and preferences
These results led to the FDA's approval of a higher dosage of the active ingredient in Ozempic, semaglutide, sold under the brand name "Wegovy" for weight loss